Oncology Resource Group (ONCrg) is the competitive intelligence vendor of choice in Gastroesophageal Cancer. Our unmatched expertise is cultivated by continuous study of the area allowing us to deliver cutting-edge reports with unparalleled depth, breadth, and insight.
Amber Mineo, Ph.D.
Therapy Area Manager
Amber received her Ph.D. in Cell and Developmental Biology at Oregon Health & Science University. During graduate school, she worked in business development and studied biomedical technology commercialization. Her combined passion for science and strategic planning provides her Gastroesophageal Cancer clients with important insights for drug development.
Lisa Komenda, Ph.D.
Therapy Area Director
Lisa received her doctorate in Molecular and Cell Biology from the University of California, Berkeley and has contributed content to our strategic, market research reports in a number of disease areas. Lisa serves clients with her strong scientific acumen, analytical aptitude and knowledge gained from her experience in early-stage regulatory consulting and in developing and implementing marketing strategies.
Pricing and More Information:
Call: 650-485-2626
Visit: www.onc-rg.com
Email: michael.reynolds@onc-rg.com
ONCrg Conference™ delivers unrivaled competitive intelligence from major congresses. ONCrg’s syndicated model covers the entire Gastroesophageal Cancer landscape, but leaves room to add or drill down on your interests, so highly relevant reports are produced, including our expert opinions about the implications of new data on your pipeline.
Competitive Landscape Analysis
ONCrg Pipeline Strategies™ delivers cutting-edge profiles across the entire Gastric Cancer competitive landscape, providing valuable analytics by class and treatment subset for new drugs in Phase I/II development and beyond. Reports are updated quarterly and written in two formats:
- a presentation format for higher level comparative analytics
- a corresponding compendium with additional detailed commentary from ONCrg experts
Monthly Surveillance Reports
ONCrg Sentinel™ provides vigilant monitoring of rapidly evolving scientific, clinical, and commercial activities in Gastroesophageal Cancer. ONCrg experts identify and analyze events and deliver incisive commentaries to inform subscribers each month and prepare them to respond wisely to changing market conditions.
Expert Advisory Guidance
ONCrg Advisory™ is an open door to ask non-proprietary questions in Gastroesophageal Cancer and your other subscription areas. Our experts utilize extensive resources and experience to provide extra guidance to inform clients’ key decisions.